NCT00177970View on ClinicalTrials.gov

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

PHASE4TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Clostridium Difficile-associated Diarrhea (CDAD)
Interventions
DRUG

intravenous immunoglobulin G (IVIG)

IVIG to be given IV to patients with C-Diff .

DRUG

Placebo

Placebo to be given IV to patients with C-Diff

Trial Locations (4)

15132

UPMC McKeesport Hospital and SemperCare Hospital of McKeesport, Inc, Pittsburgh

15213

UPMC Presbyterian Hospital, Pittsburgh

15215

UPMC St. Margaret Hospital, Pittsburgh

15232

UPMC Shadyside Hospital, Pittsburgh

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Shadyside Hospital Foundation

OTHER

collaborator

Bayer

INDUSTRY

lead

University of Pittsburgh

OTHER